NTRA
Natera Inc
414.30$
-5.0%
vs. previous close
Closing price · As of: Oct 30, 2026
Ownership
Ownership Structure
Who owns Natera Inc (NTRA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.2% of the shares are freely tradable; institutional investors hold 95.8%.
Institutional ownership
?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
95.8%
Insiders
?Share of the stock held by the executives, founders and major shareholders of the company itself.
3.0%
Float
?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
97.2%
Short % of float
?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
4.5%
Shares Outstanding
?Total number of shares issued. Price times share count gives market cap.
144Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| JPMorgan Chase & Co | 8.93 | 12,865,346 | -3.9 | 06/30/2026 |
| BlackRock Inc | 7.57 | 10,914,608 | +2.2 | 06/30/2026 |
| T. Rowe Price Associates, Inc. | 6.26 | 9,021,895 | -26.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.32 | 6,228,216 | +3.7 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 4.01 | 5,782,640 | +2.4 | 06/30/2026 |
| FMR Inc | 3.78 | 5,451,396 | +113.4 | 06/30/2026 |
| Wellington Management Company LLP | 2.80 | 4,040,738 | -15.3 | 06/30/2026 |
| State Street Corp | 2.54 | 3,655,618 | +7.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| JPMorgan Large Cap Growth I | 4.22 | 6,076,935 | +9.5 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.02 | 4,350,281 | +0.6 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | 2,117,676 | 877,353,167 $ | Sep 15, 2026 | both |
| Sheena Jonathan | Director | 234,266 | 97,056,404 $ | Oct 16, 2026 | both |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | 195,578 | 81,027,965 $ | Oct 28, 2026 | direct |
| Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | 168,221 | 69,693,960 $ | Oct 28, 2026 | direct |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 104,742 | 43,394,611 $ | Oct 28, 2026 | direct |
| Chapman Steven Leonard | CEO AND PRESIDENT | 91,232 | 37,797,418 $ | Oct 28, 2026 | direct |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 46,574 | 19,295,608 $ | Oct 30, 2026 | direct |
| Chapman Rowan E | Director | 4,663 | 1,931,881 $ | Jul 15, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 1,906 | 425.55 | 811,098 |
| Oct 28, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 865 | 426.87 | 369,245 |
| Oct 28, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 313 | 425.32 | 133,126 |
| Oct 28, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 898 | 426.34 | 382,854 |
| Oct 28, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 1,162 | 426.34 | 495,408 |
| Oct 28, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | Sell | 968 | 426.34 | 412,698 |
| Oct 28, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 3,430 | 426.34 | 1,462,348 |
| Oct 28, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 1,198 | 426.34 | 510,756 |
| Oct 28, 2026 | Sheena Jonathan | Director | Sell | 187 | 426.34 | 79,726 |
| Oct 27, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 781 | 406.00 | 317,086 |
| Oct 27, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 1,010 | 406.00 | 410,060 |
| Oct 27, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | Sell | 884 | 406.00 | 358,904 |
| Oct 27, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 2,264 | 406.00 | 919,184 |
| Oct 27, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 781 | 406.00 | 317,086 |
| Oct 27, 2026 | Sheena Jonathan | Director | Sell | 291 | 406.00 | 118,146 |
| Oct 27, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,718 | 406.00 | 697,508 |
| Oct 21, 2026 | Sheena Jonathan | Director | Sell | 165 | 416.67 | 68,751 |
| Oct 21, 2026 | Sheena Jonathan | Director | Sell | 255 | 415.67 | 105,995 |
| Oct 21, 2026 | Sheena Jonathan | Director | Sell | 125 | 413.05 | 51,631 |
| Oct 21, 2026 | Sheena Jonathan | Director | Sell | 211 | 412.20 | 86,974 |
| Oct 21, 2026 | Sheena Jonathan | Director | Sell | 605 | 411.32 | 248,847 |
| Oct 21, 2026 | Sheena Jonathan | Director | Sell | 627 | 409.89 | 257,003 |
| Oct 21, 2026 | Sheena Jonathan | Director | Sell | 962 | 408.26 | 392,745 |
| Oct 21, 2026 | Sheena Jonathan | Director | Sell | 200 | 406.50 | 81,300 |
| Oct 16, 2026 | Sheena Jonathan | Director | Sell | 98 | 409.34 | 40,116 |
| Oct 16, 2026 | Sheena Jonathan | Director | Sell | 60 | 401.62 | 24,097 |
| Oct 16, 2026 | Sheena Jonathan | Director | Sell | 142 | 398.95 | 56,651 |
| Oct 16, 2026 | Sheena Jonathan | Director | Sell | 80 | 406.06 | 32,485 |
| Oct 16, 2026 | Sheena Jonathan | Director | Sell | 35 | 406.63 | 14,232 |
| Oct 16, 2026 | Sheena Jonathan | Director | Sell | 50 | 405.15 | 20,258 |
| Oct 16, 2026 | Sheena Jonathan | Director | Sell | 90 | 403.70 | 36,333 |
| Oct 16, 2026 | Sheena Jonathan | Director | Sell | 280 | 400.68 | 112,189 |
| Oct 16, 2026 | Sheena Jonathan | Director | Sell | 215 | 399.34 | 85,858 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,000 | 408.24 | 816,471 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 3,800 | 407.27 | 1,547,612 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,400 | 406.63 | 569,282 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 6,274 | 405.18 | 2,542,096 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 10,321 | 404.64 | 4,176,306 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 3,858 | 403.27 | 1,555,798 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 6,309 | 402.23 | 2,537,684 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 5,974 | 401.42 | 2,398,094 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,671 | 400.31 | 1,069,226 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 793 | 399.31 | 316,655 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,100 | 397.16 | 436,875 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,900 | 396.30 | 752,979 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 800 | 393.47 | 314,777 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 300 | 394.40 | 118,319 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 600 | 398.09 | 238,854 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 714 | 389.84 | 278,345 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 286 | 388.32 | 111,059 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.